Condition: Metastatic Pancreatic Ductal Adenocarcinoma · Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
This study adopts a randomized, open label, placebo-controlled, multicenter trial design. OS was the primary endpoint, and eligible subjects were randomly divided into 1:1 groups and received TQB2868 injection and anlotinib hydrochloride capsules combined with chemotherapy, compared to placebo combined with chemotherapy.
This description comes directly from the study's public registry record.
Xianjun Yu, Doctor · 13801669875 · yxj@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of USTC Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Anhui Provincial Cancer Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Friendship Hospital,Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Fifth Medical Center of Chinese People's Liberation Army General Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Daxing District People'S Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Mengchao Hepatobiliary Hospital OF Fujian Medical University | Fuzhou, Fujian, China | Not Yet Recruiting |
| The Firstaffiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| Zhongshan Hospital Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| Gansu Provincial Hospital | Lanzhou, Gansu, China | Not Yet Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Not Yet Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07165951